(1)
Pelliciari, D. H. S.; Reis, C. R. A.; Bordini, C. A. Should Anti-CGRP Monoclonal Antibodies Always Be the Drug of First Choice for Migraine Prophylaxis in Brazil? – a Pharmacoeconomic Study. Headache Med 2024, 15, 98.